BE2015C068I2 - - Google Patents

Download PDF

Info

Publication number: BE2015C068I2
Authority: BE; Belgium

Application number

BE2015C068C

Other languages

French (fr)

Original Assignee

Glaxosmithkline Biologicals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-20

Filing date

2015-12-09

Publication date

2024-08-08

2015-12-09 Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa

2024-08-08 Publication of BE2015C068I2 publication Critical patent/BE2015C068I2/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Microbiology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Mycology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BE2015C068C 2002-12-20 2015-12-09 BE2015C068I2 (xx)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US43503502P	2002-12-20	2002-12-20
US49665303P	2003-08-20	2003-08-20

Publications (1)

Publication Number	Publication Date
BE2015C068I2 true BE2015C068I2 (xx)	2024-08-08

Family

ID=32685362

Family Applications (3)

Application Number	Title	Priority Date
BE2015C068C BE2015C068I2 (xx)	2002-12-20	2015-12-09
BE2015C067C BE2015C067I2 (xx)	2002-12-20	2015-12-09
BE2015C069C BE2015C069I2 (xx)	2002-12-20	2015-12-09

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
BE2015C067C BE2015C067I2 (xx)	2002-12-20	2015-12-09
BE2015C069C BE2015C069I2 (xx)	2002-12-20	2015-12-09

Country Status (29)

Country	Link
US (2)	US20060251676A1 (xx)
EP (1)	EP1572233B1 (xx)
JP (1)	JP5475939B2 (xx)
KR (3)	KR20120118087A (xx)
AP (1)	AP2005003347A0 (xx)
AR (1)	AR042530A1 (xx)
AT (1)	ATE503492T1 (xx)
AU (1)	AU2003293942B2 (xx)
BE (3)	BE2015C068I2 (xx)
BR (1)	BR0317544A (xx)
CA (1)	CA2510457C (xx)
CY (1)	CY1111552T1 (xx)
DE (1)	DE60336581D1 (xx)
DK (1)	DK1572233T3 (xx)
EA (2)	EA009179B1 (xx)
EC (1)	ECSP055869A (xx)
HK (1)	HK1085378A1 (xx)
IL (1)	IL169085A (xx)
IS (1)	IS2811B (xx)
MA (1)	MA27581A1 (xx)
MX (1)	MXPA05006764A (xx)
MY (1)	MY144492A (xx)
NO (1)	NO20052846L (xx)
NZ (1)	NZ540811A (xx)
OA (1)	OA13147A (xx)
PL (1)	PL215257B1 (xx)
PT (1)	PT1572233E (xx)
TW (1)	TWI349557B (xx)
WO (1)	WO2004056389A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000023105A2 (en) *	1998-10-16	2000-04-27	Smithkline Beecham Biologicals S.A.	Adjuvant systems and vaccines
GB0206360D0 (en)	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
US7858098B2 (en)	2002-12-20	2010-12-28	Glaxosmithkline Biologicals, S.A.	Vaccine
MXPA06014515A (es) *	2004-06-16	2007-03-23	Glaxosmithkline Biolog Sa	Vacuna contra vph16 y vph18 y al menos otro tipo de vph seleccionado de vph 31, 45 o 52.
US7758866B2 (en) *	2004-06-16	2010-07-20	Glaxosmithkline Biologicals, S.A.	Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
AU2006236905B2 (en)	2005-04-15	2010-06-03	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
SG159529A1 (en) *	2005-04-26	2010-03-30	Glaxosmithkline Biolog Sa	Vaccine
US20090181052A1 (en) *	2005-04-26	2009-07-16	Glaxosmithkline Biologicals Sa	Vaccine
EP2154147B1 (en) *	2007-04-29	2015-10-07	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	A truncated l1 protein of human papillomavirus 16
CN101570571B (zh)	2007-04-29	2012-07-11	北京万泰生物药业股份有限公司	截短的人乳头瘤病毒18型l1蛋白
ES2671880T3 (es) *	2009-03-05	2018-06-11	Jenny Colleen Mccloskey	Tratamiento de infección
PL2444103T3 (pl) *	2009-06-19	2018-05-30	Eyegene Inc.	Szczepionka przeciwko rakowi szyjki macicy
US20170212116A1 (en)	2014-01-31	2017-07-27	Ulisse Biomed Srl	Biosensors for the detection of infection and associated maladies
US10799574B2 (en)	2014-10-24	2020-10-13	Hpvvax. Llc	Method and composition for treating cancer or skin lesion using a vaccine
MX2017005418A (es)	2014-10-24	2017-11-30	Hpvvax Llc	Tratamiento de cancer y lesion de piel.
CN107614009A (zh) *	2015-06-02	2018-01-19	泰尔茂株式会社	含有铝的佐剂组合物及包含其的疫苗组合物
WO2019173463A1 (en)	2018-03-06	2019-09-12	Intrexon Corporation	Hepatitis b vaccines and uses of the same
WO2019173465A1 (en) *	2018-03-06	2019-09-12	Intrexon Corporation	Human papillomavirus vaccines and uses of the same
WO2019233412A1 (zh) *	2018-06-04	2019-12-12	厦门大学	一种人乳头瘤病毒18型l1蛋白的突变体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332596A1 (de) *	1993-09-24	1995-03-30	Martin Josef Dr Sapp	Monoklonale Antikörper
AU742409B2 (en)	1997-09-05	2002-01-03	Medimmune, Llc	In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs)
SI1150712T1 (sl) *	1999-02-05	2009-02-28	Merck & Co Inc	Pripravek cepiva proti humanem papiloma virusu
US6245568B1 (en)	1999-03-26	2001-06-12	Merck & Co., Inc.	Human papilloma virus vaccine with disassembled and reassembled virus-like particles
GB9921146D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
US6908613B2 (en) *	2000-06-21	2005-06-21	Medimmune, Inc.	Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
AU2001271449B2 (en) *	2000-06-26	2006-08-24	Nventa Biopharmaceuticals Corporation	Human papilloma virus treatment

2003
- 2003-12-18 JP JP2005502554A patent/JP5475939B2/ja not_active Expired - Lifetime
- 2003-12-18 BR BR0317544-8A patent/BR0317544A/pt not_active Application Discontinuation
- 2003-12-18 AT AT03789346T patent/ATE503492T1/de active
- 2003-12-18 AR ARP030104709A patent/AR042530A1/es unknown
- 2003-12-18 EP EP03789346A patent/EP1572233B1/en not_active Expired - Lifetime
- 2003-12-18 CA CA2510457A patent/CA2510457C/en not_active Expired - Lifetime
- 2003-12-18 PT PT03789346T patent/PT1572233E/pt unknown
- 2003-12-18 MX MXPA05006764A patent/MXPA05006764A/es active IP Right Grant
- 2003-12-18 TW TW092135963A patent/TWI349557B/zh not_active IP Right Cessation
- 2003-12-18 EA EA200500834A patent/EA009179B1/ru not_active IP Right Cessation
- 2003-12-18 WO PCT/EP2003/014562 patent/WO2004056389A1/en active Application Filing
- 2003-12-18 PL PL377710A patent/PL215257B1/pl unknown
- 2003-12-18 OA OA1200500189A patent/OA13147A/en unknown
- 2003-12-18 DK DK03789346.8T patent/DK1572233T3/da active
- 2003-12-18 KR KR1020127026719A patent/KR20120118087A/ko not_active Application Discontinuation
- 2003-12-18 NZ NZ540811A patent/NZ540811A/en not_active IP Right Cessation
- 2003-12-18 EA EA200701633A patent/EA200701633A1/ru unknown
- 2003-12-18 DE DE60336581T patent/DE60336581D1/de not_active Expired - Lifetime
- 2003-12-18 US US10/540,099 patent/US20060251676A1/en not_active Abandoned
- 2003-12-18 KR KR1020127027784A patent/KR101361769B1/ko active IP Right Grant
- 2003-12-18 KR KR1020057011497A patent/KR20050086924A/ko active Application Filing
- 2003-12-18 AU AU2003293942A patent/AU2003293942B2/en not_active Expired
- 2003-12-18 MY MYPI20034868A patent/MY144492A/en unknown
- 2003-12-18 AP AP2005003347A patent/AP2005003347A0/xx unknown
2005
- 2005-04-26 US US11/114,301 patent/US20050287161A1/en not_active Abandoned
- 2005-06-09 IS IS7885A patent/IS2811B/is unknown
- 2005-06-09 IL IL169085A patent/IL169085A/en active IP Right Grant
- 2005-06-13 NO NO20052846A patent/NO20052846L/no not_active Application Discontinuation
- 2005-06-20 EC EC2005005869A patent/ECSP055869A/es unknown
- 2005-07-18 MA MA28398A patent/MA27581A1/fr unknown
2006
- 2006-03-02 HK HK06102781.3A patent/HK1085378A1/xx not_active IP Right Cessation
2011
- 2011-06-08 CY CY20111100549T patent/CY1111552T1/el unknown
2015
- 2015-12-09 BE BE2015C068C patent/BE2015C068I2/fr unknown
- 2015-12-09 BE BE2015C067C patent/BE2015C067I2/fr unknown
- 2015-12-09 BE BE2015C069C patent/BE2015C069I2/fr unknown

Also Published As

Publication number	Publication date
US20060251676A1 (en)	2006-11-09
WO2004056389A1 (en)	2004-07-08
HK1085378A1 (en)	2006-08-25
EA200701633A1 (ru)	2007-12-28
US20050287161A1 (en)	2005-12-29
IS7885A (is)	2005-06-09
EA009179B1 (ru)	2007-12-28
MXPA05006764A (es)	2005-09-08
IS2811B (is)	2012-11-15
IL169085A (en)	2014-04-30
AU2003293942A1 (en)	2004-07-14
ATE503492T1 (de)	2011-04-15
CA2510457C (en)	2011-12-06
AU2003293942B2 (en)	2009-12-10
DE60336581D1 (de)	2011-05-12
PL215257B1 (pl)	2013-11-29
KR20050086924A (ko)	2005-08-30
CY1111552T1 (el)	2015-08-05
AR042530A1 (es)	2005-06-22
KR101361769B1 (ko)	2014-02-10
IL169085A0 (en)	2007-07-04
JP5475939B2 (ja)	2014-04-16
PT1572233E (pt)	2011-06-07
ECSP055869A (es)	2005-09-20
JP2006512413A (ja)	2006-04-13
DK1572233T3 (da)	2011-06-27
NO20052846L (no)	2005-07-13
CA2510457A1 (en)	2004-07-08
MY144492A (en)	2011-09-30
MA27581A1 (fr)	2005-10-03
NZ540811A (en)	2007-03-30
AP2005003347A0 (en)	2005-06-30
BE2015C069I2 (xx)	2024-08-08
EP1572233B1 (en)	2011-03-30
KR20120123616A (ko)	2012-11-08
TWI349557B (en)	2011-10-01
BE2015C067I2 (xx)	2024-08-08
OA13147A (en)	2006-12-13
KR20120118087A (ko)	2012-10-25
EP1572233A1 (en)	2005-09-14
TW200423957A (en)	2004-11-16
BR0317544A (pt)	2005-11-22
PL377710A1 (pl)	2006-02-06
EA200500834A1 (ru)	2006-02-24

Publication	Publication Date	Title
BE2019C547I2 (xx)	2022-05-17
BE2019C510I2 (xx)	2022-05-19
BE2018C021I2 (xx)	2023-03-07
BE2017C049I2 (xx)	2022-08-09
BE2017C005I2 (xx)	2022-05-17
BE2016C069I2 (xx)	2022-05-17
BE2016C040I2 (xx)	2022-05-17
BE2016C013I2 (xx)	2022-05-17
BE2015C078I2 (xx)	2022-08-09
BE2016C002I2 (xx)	2023-03-07
BE2018C018I2 (xx)	2023-03-07
BE2015C017I2 (xx)	2022-09-22
IL182742A0 (xx)	2007-07-24
JP2003232645A5 (xx)	2006-04-13
BE2015C067I2 (xx)	2024-08-08
JP2003233339A5 (xx)	2005-08-04
JP2003199112A5 (xx)	2008-04-03
JP2003230184A5 (xx)	2005-12-02
BRPI0215435A2 (xx)	2004-12-14
JP2003150322A5 (xx)	2005-12-02
JP2003162892A5 (xx)	2005-10-27
JP2003225373A5 (xx)	2006-12-14
JP2003227884A5 (xx)	2005-07-21
JP2003201380A5 (xx)	2005-07-07
HU0202043D0 (xx)	2002-08-28